TGA plans OTC ad reforms
June 19, 2013
THE Therapeutic Goods
Administration has outlined
proposals to reform the current
“pre-approval” system for
advertisements for OTC products,
as well as improve the efficiency of
the complaints handling process.
According to a presentation at
last week’s CHC advertising seminar
by TGA Director, Recalls and
Advertising Review, Mick O’Connor,
the aim is to create a “robust and
effective system of advertising
controls” to communicate truth
about products and enhance health
outcomes for Australians.
Currently the TGA is developing
a range of tools to enhance
consistency in decisions by its
Advertising Services Managers,
including a common standard
operating procedure and an
improved application form for
advertising approval.
Claims made in advertising must
be consistent with approved
indications, and advertisers must
hold the “appropriate level of
evidence to verify all claims”.
CLICK HERE to view the paper.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Jun 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Jun 13
